• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂毒性对糖尿病肾病的贡献。

The Contribution of Lipotoxicity to Diabetic Kidney Disease.

机构信息

Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106-4921, USA.

出版信息

Cells. 2022 Oct 14;11(20):3236. doi: 10.3390/cells11203236.

DOI:10.3390/cells11203236
PMID:36291104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9601125/
Abstract

Lipotoxicity is a fundamental pathophysiologic mechanism in diabetes and non-alcoholic fatty liver disease and is now increasingly recognized in diabetic kidney disease (DKD) pathogenesis. This review highlights lipotoxicity pathways in the podocyte and proximal tubule cell, which are arguably the two most critical sites in the nephron for DKD. The discussion focuses on membrane transporters and lipid droplets, which represent potential therapeutic targets, as well as current and developing pharmacologic approaches to reduce renal lipotoxicity.

摘要

脂毒性是糖尿病和非酒精性脂肪肝的基本病理生理机制,目前在糖尿病肾病(DKD)发病机制中也越来越受到重视。本文重点介绍了足细胞和近端肾小管细胞中的脂毒性途径,这两个细胞可以说是肾病中最重要的两个部位。本文讨论了膜转运蛋白和脂滴,它们是潜在的治疗靶点,以及目前和正在开发的降低肾脏脂毒性的药物治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c498/9601125/e4e27f654191/cells-11-03236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c498/9601125/056310f35e38/cells-11-03236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c498/9601125/e4e27f654191/cells-11-03236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c498/9601125/056310f35e38/cells-11-03236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c498/9601125/e4e27f654191/cells-11-03236-g002.jpg

相似文献

1
The Contribution of Lipotoxicity to Diabetic Kidney Disease.脂毒性对糖尿病肾病的贡献。
Cells. 2022 Oct 14;11(20):3236. doi: 10.3390/cells11203236.
2
CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.CCDC92 缺乏可改善糖尿病肾病足细胞的脂毒性。
Metabolism. 2024 Jan;150:155724. doi: 10.1016/j.metabol.2023.155724. Epub 2023 Nov 11.
3
Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells.硬脂酰辅酶A去饱和酶-1保护细胞免受近端肾小管细胞中脂毒性介导的细胞凋亡。
Int J Mol Sci. 2016 Nov 9;17(11):1868. doi: 10.3390/ijms17111868.
4
Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease.足细胞特异性 KLF6 激活近端肾小管 CaMK1D 信号通路,从而减轻糖尿病肾病。
Nat Commun. 2024 Sep 13;15(1):8038. doi: 10.1038/s41467-024-52306-5.
5
Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.降低 VEGF-B 信号可改善肾脏脂毒性并预防糖尿病肾病。
Cell Metab. 2017 Mar 7;25(3):713-726. doi: 10.1016/j.cmet.2017.01.004. Epub 2017 Feb 9.
6
Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling.通过靶向 Rev-Erbα/FABP5 信号转导,遗传或药理学阻断 mPGES-2 可减轻肾脏脂肪毒性和糖尿病肾病。
Cell Rep. 2024 Apr 23;43(4):114075. doi: 10.1016/j.celrep.2024.114075. Epub 2024 Apr 6.
7
DESI-MSI and METASPACE indicates lipid abnormalities and altered mitochondrial membrane components in diabetic renal proximal tubules.DESI-MSI 和 METASPACE 表明糖尿病肾脏近端小管中的脂质异常和线粒体膜成分改变。
Metabolomics. 2020 Jan 10;16(1):11. doi: 10.1007/s11306-020-1637-8.
8
Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.脂毒性失调导致 2 型糖尿病中肾小球足细胞和肾脏的免疫蛋白酶体紊乱。
Am J Physiol Renal Physiol. 2021 Apr 1;320(4):F548-F558. doi: 10.1152/ajprenal.00509.2020. Epub 2021 Feb 15.
9
GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway.GPR43 激活介导的脂毒性通过调节 ERK/EGR1 通路导致糖尿病肾病足细胞损伤。
Int J Biol Sci. 2022 Jan 1;18(1):96-111. doi: 10.7150/ijbs.64665. eCollection 2022.
10
Lipin-1 deficiency deteriorates defect of fatty acid β-oxidation and lipid-related kidney damage in diabetic kidney disease.脂联素-1 缺乏可加重糖尿病肾病中脂肪酸β-氧化缺陷及脂质相关的肾脏损害。
Transl Res. 2024 Apr;266:1-15. doi: 10.1016/j.trsl.2023.07.004. Epub 2023 Jul 9.

引用本文的文献

1
Sirtuin 3 in diabetic kidney disease: mechanisms and pharmacotherapy.糖尿病肾病中的沉默调节蛋白3:机制与药物治疗
Ren Fail. 2025 Dec;47(1):2543927. doi: 10.1080/0886022X.2025.2543927. Epub 2025 Aug 19.
2
Lipidomics Unveils Critical Lipid Pathway Shifts in Alport Syndrome.脂质组学揭示了阿尔波特综合征中关键脂质途径的变化。
Kidney Int Rep. 2025 May 26;10(8):2805-2820. doi: 10.1016/j.ekir.2025.05.034. eCollection 2025 Aug.
3
Research progress in the treatment of lipid metabolism disorder in patients with diabetic kidney disease by the integrated traditional Chinese and Western medicine.

本文引用的文献

1
Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease.盐皮质激素受体拮抗剂用于糖尿病肾病的网状Meta分析
Front Pharmacol. 2022 Sep 16;13:967317. doi: 10.3389/fphar.2022.967317. eCollection 2022.
2
A Systematic Review on the Safety and Efficacy of PCSK9 Inhibitors in Lowering Cardiovascular Risks in Patients With Chronic Kidney Disease.一项关于前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂降低慢性肾脏病患者心血管风险的安全性和有效性的系统评价。
Cureus. 2022 Sep 13;14(9):e29140. doi: 10.7759/cureus.29140. eCollection 2022 Sep.
3
Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States-Current View of Knowledge.
中西医结合治疗糖尿病肾病患者脂质代谢紊乱的研究进展
Front Endocrinol (Lausanne). 2025 Jul 30;16:1631312. doi: 10.3389/fendo.2025.1631312. eCollection 2025.
4
Decreased Serum Adipose Triglyceride Lipase Level Is Associated With Renal Function Impairment in Patients With Type 2 Diabetes.血清脂肪甘油三酯脂肪酶水平降低与2型糖尿病患者肾功能损害相关。
J Diabetes Res. 2025 Jul 24;2025:9987648. doi: 10.1155/jdr/9987648. eCollection 2025.
5
Polysaccharides Ameliorated Diabetic Kidney Disease in Mice via Inhibiting TGF/Smad2 Signaling Pathway.多糖通过抑制TGF/Smad2信号通路改善小鼠糖尿病肾病。
Food Sci Nutr. 2025 Jul 18;13(7):e70677. doi: 10.1002/fsn3.70677. eCollection 2025 Jul.
6
Sodium-Glucose Cotransporter-2 Inhibitor Improves Renal Injury by Regulating the Redox Profile, Inflammatory Parameters, and Pyroptosis in an Experimental Model of Diabetic Kidney Disease.钠-葡萄糖协同转运蛋白2抑制剂通过调节糖尿病肾病实验模型中的氧化还原状态、炎症参数和细胞焦亡来改善肾损伤。
ACS Pharmacol Transl Sci. 2025 Apr 16;8(5):1270-1281. doi: 10.1021/acsptsci.4c00552. eCollection 2025 May 9.
7
Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies.靶向脂质代谢重编程以减轻糖尿病肾病:分子见解与治疗策略
Front Immunol. 2025 Apr 25;16:1549484. doi: 10.3389/fimmu.2025.1549484. eCollection 2025.
8
Renal ectopic fat deposition and hemodynamics in type 2 diabetes mellitus assessment with magnetic resonance imaging.2型糖尿病患者肾脏异位脂肪沉积及血流动力学的磁共振成像评估
Insights Imaging. 2025 Apr 27;16(1):93. doi: 10.1186/s13244-025-01971-1.
9
Renal Lipid Alterations From Diabetes to Early-Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin.从糖尿病到早期糖尿病肾病的肾脏脂质改变与线粒体自噬:聚焦于心磷脂
J Cell Mol Med. 2025 Feb;29(3):e70419. doi: 10.1111/jcmm.70419.
10
UHRF1 promotes calcium oxalate-induced renal fibrosis by renal lipid deposition via bridging AMPK dephosphorylation.UHRF1通过衔接AMPK去磷酸化,经由肾脏脂质沉积促进草酸钙诱导的肾纤维化。
Cell Biol Toxicol. 2025 Feb 3;41(1):39. doi: 10.1007/s10565-025-09991-9.
脂毒性的分子机制:病理状态发展过程中的一个有趣方面——当前知识的视角。
Cells. 2022 Mar 1;11(5):844. doi: 10.3390/cells11050844.
4
DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants.DGAT2 抑制作用增强脂滴形成,降低 APOL1 肾脏风险变异体的细胞毒性。
J Am Soc Nephrol. 2022 May;33(5):889-907. doi: 10.1681/ASN.2021050723. Epub 2022 Mar 1.
5
Fatty acid transport protein 2 interacts with ceramide synthase 2 to promote ceramide synthesis.脂肪酸转运蛋白 2 与神经酰胺合酶 2 相互作用以促进神经酰胺合成。
J Biol Chem. 2022 Apr;298(4):101735. doi: 10.1016/j.jbc.2022.101735. Epub 2022 Feb 16.
6
Adaptive and maladaptive roles of lipid droplets in health and disease.脂滴在健康和疾病中的适应性和失调性作用。
Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C468-C481. doi: 10.1152/ajpcell.00239.2021. Epub 2022 Feb 2.
7
Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway.白藜芦醇通过减轻脂毒性并调节连接黏附分子样/沉默调节蛋白 1 脂质代谢途径的成分表达来改善糖尿病肾病损伤。
Eur J Pharmacol. 2022 Mar 5;918:174776. doi: 10.1016/j.ejphar.2022.174776. Epub 2022 Jan 25.
8
Lipid droplet-mitochondria coupling via perilipin 5 augments respiratory capacity but is dispensable for FA oxidation.通过 perilipin 5 实现脂滴-线粒体偶联可增强呼吸能力,但对于 FA 氧化却是可有可无的。
J Lipid Res. 2022 Mar;63(3):100172. doi: 10.1016/j.jlr.2022.100172. Epub 2022 Jan 21.
9
GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway.GPR43 激活介导的脂毒性通过调节 ERK/EGR1 通路导致糖尿病肾病足细胞损伤。
Int J Biol Sci. 2022 Jan 1;18(1):96-111. doi: 10.7150/ijbs.64665. eCollection 2022.
10
Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling.白藜芦醇通过分子信号通路在糖尿病肾病中的治疗潜力
Curr Mol Pharmacol. 2022;15(5):716-735. doi: 10.2174/1874467215666211217122523.